Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

How successful are commercial weight-loss programs?

Paul M Copeland¹

¹Endocrinology Division, North Shore Medical Center, Salem, MA, USA. pcopeland@partners.org

Nature Clinical Practice. Endocrinology & Metabolism

|December 5, 2006

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Results of a 2-year lifestyle intervention for type 2 diabetes: the Reach Ahead for Lifestyle and Health-Diabetes randomized controlled trial.

Obesity (Silver Spring, Md.)·2022

Same author

Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder.

Clinical schizophrenia & related psychoses·2017

Same author

Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses.

The lancet. Psychiatry·2015

Same author

A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism.

Schizophrenia research·2014

Same author

An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2013

Same author

Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia.

Journal of clinical psychopharmacology·2011